Two Sigma Investments
TCRT icon

Two Sigma Investments’s Alaunos Therapeutics TCRT Stock Holding History

Two Sigma Investments’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,839
Closed -$31K – 5423
2026
Q1 		$31K Sell
10,839
-7,749
-42% -$23.2K ﹤0.01% 4495
2025
Q4 		$60K Buy
+18,588
New +$60.1K ﹤0.01% 3915
2024
Q1 		– Sell
-2,010
Closed -$21.3K – 3384
2023
Q4 		$21.3K Sell
2,010
-51
-2% -$614 ﹤0.01% 3051
2023
Q3 		$40.8K Sell
2,061
-717
-26% -$30.9K ﹤0.01% 2832
2023
Q2 		$213K Sell
2,778
-3,762
-58% -$304K ﹤0.01% 2628
2023
Q1 		$618K Sell
6,540
-4,372
-40% -$416K ﹤0.01% 2108
2022
Q4 		$1.06M Buy
10,912
+8,066
+283% +$1.17M ﹤0.01% 1665
2022
Q3 		$734K Sell
2,846
-226
-7% -$65.6K ﹤0.01% 1598
2022
Q2 		$571K Sell
3,072
-8,812
-74% -$842K ﹤0.01% 1775
2022
Q1 		$1.16M Sell
11,884
-5,651
-32% -$725K ﹤0.01% 1642
2021
Q4 		$2.87M Buy
17,535
+14,498
+477% +$3.19M 0.01% 1608
2021
Q3 		$829K Sell
3,037
-2,462
-45% -$753K ﹤0.01% 2788
2021
Q2 		$2.18M Sell
5,499
-971
-15% -$453K ﹤0.01% 1786
2021
Q1 		$3.49M Buy
6,470
+764
+13% +$476K 0.01% 1289
2020
Q4 		$2.16M Buy
5,706
+589
+12% +$234K 0.01% 1448
2020
Q3 		$1.93M Buy
5,117
+5,005
+4,469% +$2.21M 0.01% 1312
2020
Q2 		$55K Sell
112
-2,870
-96% -$1.28M ﹤0.01% 2836
2020
Q1 		$1.1M Buy
2,982
+2,132
+251% +$1.1M 0.01% 1340
2019
Q4 		$602K Buy
850
+145
+21% +$99.8K ﹤0.01% 2639
2019
Q3 		$453K Buy
+705
New +$559K ﹤0.01% 2639
2019
Q1 		– Sell
-756
Closed -$212K – 3454
2018
Q4 		$212K Buy
+756
New +$299K ﹤0.01% 2679
2015
Q3 		– Sell
-460
Closed -$827K – 2713
2015
Q2 		$827K Sell
460
-1,472
-76% -$2.29M ﹤0.01% 1786
2015
Q1 		$3.12M Buy
+1,932
New +$2.86M 0.01% 940
2014
Q2 		– Sell
-217
Closed -$149K – 2346
2014
Q1 		$149K Buy
+217
New +$145K ﹤0.01% 1845

Other funds holding TCRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments's TCRT Position: Q2 2026 in Review

Two Sigma Investments sold out of Alaunos Therapeutics (TCRT) in Q2 2026, closing a stake of 10,839 shares — an estimated $31K sold.

Two Sigma Investments first reported a position in TCRT in Q1 2014 and held it in 24 quarters. The position peaked at $3.49M in Q1 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • Two Sigma Investments reported no remaining Alaunos Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Investments sold 10,839 Alaunos Therapeutics shares in Q2 2026, an estimated $31K.
  • Two Sigma Investments first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 24 quarters.
  • Two Sigma Investments's Alaunos Therapeutics position peaked at $3.49M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.